Skip to content

Study on Predicting Adverse Pregnancy Outcomes of Intrahepatic Cholestasis of Pregnancy Based on Multi-source Heterogeneous Data and Machine Learning Algorithms

Study on Predicting Adverse Pregnancy Outcomes of Intrahepatic Cholestasis of Pregnancy Based on Multi-source Heterogeneous Data and Machine Learning Algorithms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120148
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-03-10
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic Cholestasis of Pregnancy

Interventions

Sponsors

Chengdu Women and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Presence of typical pruritus without rash, and exclusion of other diseases that may cause pruritus. 2.Maternal fasting total bile acid (TBA) >= 10 µmol/L or postprandial TBA >= 19 µmol/L. 3.In cases with normal serum total bile acid concentration but unexplained liver function abnormalities, mainly elevated serum alanine aminotransferase and aspartate aminotransferase, which may be accompanied by increased serum bilirubin and gamma-glutamyl transferase concentrations. 4.Pruritus and liver function abnormalities resolve spontaneously after delivery. 5.The diagnosis of ICP must be established by excluding other causes of pruritus or abnormal laboratory results such as elevated serum TBA. Routine ultrasound examination is recommended to rule out hepatobiliary diseases in pregnant women.

Exclusion criteria

Exclusion criteria: 1.Complications during pregnancy including hypertensive disorders of pregnancy, gestational hyperglycemia, nephropathy, thyroid disease, autoimmune disease, or use of other medications affecting liver function (e.g., heparinoids). 2.Complications during pregnancy including primary hepatobiliary diseases such as viral hepatitis, acute fatty liver of pregnancy, cholecystolithiasis, primary biliary cholangitis. 3.Patients with systemic or local infectious symptoms during pregnancy. 4.Patients with incomplete laboratory test results or data during pregnancy.

Design outcomes

Primary

MeasureTime frame
Adverse pregnancy outcomes;

Secondary

MeasureTime frame
Receiver Operating Characteristic curve;Area Under the Curve;Accuracy Rate (ACC);Recall;F1 Score;Decision Curve Analysis;Calibration Curve;

Countries

China

Contacts

Public ContactYi Deng

Chengdu Women and Children's Central Hospital

9306179@qq.com+86 28 61866157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026